• Explore /
  • Poster
  • / Application of artificial intelligence (AI) features of nuclear morphology from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy.

Application of artificial intelligence (AI) features of nuclear morphology from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy.

Abstract Poster

Authors

null

Kamal Hammouda

Emory University, Atlanta, GA

Kamal Hammouda , Shilpa Gupta , Tilak Pathak , Guru P. Sonpavde , Ewan Gibb , Sumati Gupta , Benjamin L. Maughan , Neeraj Agarwal , Bradley Alexander McGregor , Matthew Mossanen , C. Marcela Diaz-Montero , Peter C. Black , Christopher Weight , Tuomas Mirtti , Badrinath R. Konety , Anant Madabhushi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 674)

DOI

10.1200/JCO.2024.42.4_suppl.674

Abstract #

674

Poster Bd #

K18

Abstract Disclosures

Similar Posters

First Author: Shilpa Gupta

First Author: Shilpa Gupta

First Author: Michael Lattanzi

First Author: Samuel Aaron Funt